Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Drug eluting stents significantly reduced the rate of in-stent restenosis in coronary arteries. There are several kinds of DES i.e. eluting the drug either from stable or biodegradable polymer. The type of the polymer may impact the clinical outcome. The aim of our study was to compare safety and efficacy of implantation of two different types of stents eluting paclitaxel from stable vs biodegradable polymer (TAXUS stent vs LUC-CHOPIN stent) into coronary artery by-pass graft.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| T | Experimental | Implantation of Taxus stent into saphenous vein graft |
|
| C | Experimental | Implantation of Luc-Chopin stent into saphenous vein graft |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Taxus stent implantation | Device | Patients will be treated with implantation of Taxus stent |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Neointima hyperplasia volume by Intravascular Ultrasound | 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| All cause mortality | 5 years | |
| Cardiovascular mortality | 5 years | |
| Stent thrombosis |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Adam R Witkowski, MD,PhD | National Institute of Cardiology, Warsaw, Poland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institute of Cardiology | Warsaw | 04-628 | Poland |
Not provided
Not provided
Not provided
Not provided
Not provided
| Luc-Chopin stent |
| Device |
Patients will be treated will implantation of Luc-Chopin stent |
|
| 5 years |
| Target lesion revascularization | 5 years |
| Angiographic late loss | 9 months |